Released: 10/30/2009
Expires: 10/30/2010

Target Audience
The target audience for this activity is physicians, nurses, and pharmacists.

Learning Objectives
At the completion of this activity participants should be able to:

• Identify traditional anthracycline-based treatments for non-Hodgkin’s lymphoma (NHL) and discuss the need for newer, more effective therapies.
• Describe novel treatment approaches for newly diagnosed and refractory/relapsed NHL and recent clinical findings on the safety and efficacy of these therapies.
• Explore common toxicities associated with various agents used to treat NHL and discuss appropriate management strategies.

Physician Accreditation
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Registered Nurse Designation
The University of Nebraska Medical Center, Col lege of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is provided for 1.5 contact hours under ANCC criteria. Provided for 1.8 contact hours under Iowa Provider #78. Provider approved by the California Board of Registered Nursing, Provider #13699 for 1.8 contact hours.

Registered Pharmacy Designation
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE provider number is 0447-9999-09-082-H04-P. To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the activity. Approval is valid from the initial release date of October 30, 2009. The expiration date is October 30, 2010. A statement of credit will be available for printing online upon completion of the post-test with a score of 70% or better and the evaluation instrument.

The estimated time to complete this activity: 60-90 minutes.

Instructions for Credit
There is no fee for this activity. To receive credit, participants must:

• Review the entire activity
• Log on to www.unmc.edu/cce/ocme_nhl
• Successfully complete the post-test (70% accuracy)
• Complete the evaluation instrument
• Print your certificate online

Disclosure Statement
All planners and faculty participating in continuing education activities provided by the University of Nebraska Medical Center, Center for Continuing Education are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. Having an interest in or affiliation with a commercial entity does not preclude making a presentation at a CME activity, but the relationship must be disclosed in advance and any potential conflict of interest must be resolved in accordance with the ACCME Updated Standards for Commercial Support. The planners and faculty have been advised that this activity must be free from commercial bias and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis. Disclosure of these commitments and/or relationships is included in the materials so that participants in the activity may formulate their own judgment in interpreting its content and evaluating its recommendations.

The authors, reviewers, and planning committee members listed below have stated they have no significant or substantial relationship with providers or commercial products and/or devices discussed in this activity and/or with any commercial supporter of this activity.

• Lisa Anzai, RN, MA
• Barbara Bekiesz
• Susan Berry
• Catherine Bevil, RN, EdD
• Katherine L. Byar, MSN, APRN, BC
• Lois Colburn
• Brenda Ram, CMP

Faculty Disclosures
Betty M. Chan, PharmD, BCOP has received research/grant support from Merck & Co.

Katherine L. Byar, MSN, APRN, BC has nothing to disclose.


*Content will include non-FDA-approved uses.

Disclaimer
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center, Center for Continuing Education and Center of Excellence Media, LLC.

Healthcare professionals and other individuals should review and consider other publications and materials on the subject before relying solely upon the information contained within this educational activity.

Contact Information
If you have any questions about this activity, please contact Brenda Ram, CMP, in the Center for Continuing Education at the University of Nebraska Medical Center, 402-559-9250, or via email at bram@unmc.edu.